Advertisement

Immunology in Genesis of Partial and Total Hydatidiform Mole

  • Shoshichi Takeuchi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 176)

Abstract

In early pregnancy, a variety of pathology of trophoblastic cells is observed in trophoblastic disease and in spontaneous abortion. Trophoblastic disease includes hydatidiform mole, metastatic and/or invasive mole, and choriocarcinoma. Therefore, for better understanding of trophoblastic disease and spontaneous abortion, an exact knowledge of the morbid anatomy of trophoblasts is required. Especially needed is profound insight into regulatory mechanisms of in vivo trophoblastic growth which may undergo either damage or proliferation and survival. But the regulatory mechanisms are not clear because of their complexity, involving cellular factors such as benign or malignant neoplastic cellular changes, and/or environmental factors such as nutritional, endocrinological, and immunological factors.

Keywords

Chromosomal Anomaly Spontaneous Abortion Myometrial Invasion Hydatidiform Mole Total Mole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hertz, R., “Choriocarcinoma and Related Gestational Trophoblastic Tumors in Women,” Raven Press (1978).Google Scholar
  2. 2.
    Park, W. W., “Choriocarcinoma. A Study of Its Pathology,” F. A. Davis, Philadelphia (1971).Google Scholar
  3. 3.
    Goldstein, D. P. and Berkowicz, R. S., “Gestational Trophoblastic Neoplasms - Clinical Principles of Diagnosis and Management,” W. B. Saunders Co., New York (1982).Google Scholar
  4. 4.
    Kajii, T. and Ohama, K., Androgenetic origin of hydatidiform mole, Nature 268:633 (1977).PubMedCrossRefGoogle Scholar
  5. 5.
    Wake, N., Takagi, N., and Sasaki, M., Androgenesis as a cause of hydatidiform mole, J. Natl. Cancer Inst. 60:51 (1978).PubMedGoogle Scholar
  6. 6.
    Jacobs, P. A., Angel, R. R., Buchananan, I. M., Hassold, T. J., Matsuyama, A. M., and Mannuel, B., Chromosome constitution of gestational trophoblastic disease, Lancet 11:49 (1978).CrossRefGoogle Scholar
  7. 7.
    Lawler, S. D., Pickthall, V. J., Fisher, R., Povey, S., Evens, M. W., and Szulman, A. E., Genetic studies of complete and partial hydatidiform mole, Lancet 11:580 (1979).CrossRefGoogle Scholar
  8. 8.
    Yamashita, K., Wake, N., Araki, T., et al, Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm, Amer. J. Obstet. Gynecol. 135:597 (1979).Google Scholar
  9. 9.
    Ohama, K., Kajii, T., Okamoto, E., et al., Dispermic origin of XY hydatidiform mole, Nature 292:551 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    Surti, U., Szulman, A. E., and O-Brien, S., Complete (classic) hydatidiform mole with 46,XY karyotype of paternal origin, Human Genet. 51:153 (1979).CrossRefGoogle Scholar
  11. 11.
    Pattillo, R., Sasaki, S., Katayama, K., Roesler, M., and Mattingly, R., Genesis of 46,XY hydatidiform mole, Amer. J. Obstet. Gynecol. 141:104 (1981).Google Scholar
  12. 12.
    Jacobs, P. A., Szulman, A. E., Funkhouser, J., Matsuura, J. S., and Wilson, C. C., Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole, Ann. Hum. Genet. 46: 223 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    Lawler, S. D., Pickthall, V. J., Povey, S., and Evens, M. W., Genetic studies on hydatidiform moles. 1. The origin of partial moles, Cancer Genetics and Cytogenetics (1982).Google Scholar
  14. 14.
    Szulman, A. E., Philipp, E., Boue, J. G., and Boue, A., Human triploidy: association with partial hydatidiform moles and non-molar conceptuses, Human Pathology 12:1016 (1981).PubMedCrossRefGoogle Scholar
  15. 15.
    Szulman, A. E. and Surti, U., The clinico-pathological profile of the partial hydatidiform mole, Obstet. Gynecol. (1982).Google Scholar
  16. 16.
    Boue, J., Boue, A., and Lazal, P., Retrospective and prospective epidemiological studies of 15,000 karyotyped spontaneous human abortions, Teratology 12:11 (1975).PubMedCrossRefGoogle Scholar
  17. 17.
    Car, D. H., Chromosomes and abortion, in: “Advances in Human Genetics,” H. Harris and K. Hirshhorn, eds., Plenum Press, New York (1971), p. 201.Google Scholar
  18. 18.
    Kajii, T. and Ferrier, A., Cytogenetics of aborters and abortuses, Amer. J. Obstet. Gynecol. 131:33 (1978).Google Scholar
  19. 19.
    Beer, A. E. and Billingham, R. E., “The Immunobiology of Mammalian Reproduction,” Prentice-Hall, Englewood Cliffs, N. J. (1976).Google Scholar
  20. 20.
    Beer, A. E. and Billingham, R. E., Mechanisms of nonrejection of feto-placental allografts, Folia Biologica (1980).Google Scholar
  21. 21.
    Loke, Y. W., “Immunology and Immunopathology of the Human Foetal Maternal Interaction,” Elsevier-North Holland, Amsterdam (1978).Google Scholar
  22. 22.
    Voisin, G. A., Role of antibody class in the regulatory facilitation reaction, Immunol. Rev. 49:3 (1980).Google Scholar
  23. 23.
    Takeuchi, S., Immunology of spontaneous abortion and hydatidiform mole, Amer. J. Reprod. Immunol. 1:23 (1980).Google Scholar
  24. 24.
    Takeuchi, S., An immune dependency of trophoblastic growth implied by the antithetic difference in immunology between spontaneous abortion and hydatidiform mole, in: “Reproductive Immunology,” N. Gleicher, ed., Alan R. Liss, Inc., New York (1981), p. 245.Google Scholar
  25. 25.
    Takeuchi, S., Immunology of growth and demise of embryo-trophoblast unit indicated by comparative study between abortion and hydatidiform mole - A nature’s experiment system, in: “Immunobiology of Transplantation, Cancer and Pregnancy,” P. K. Ray, ed., Pergamon Press, New York (1983).Google Scholar
  26. 26.
    Takeuchi, S., Definition and classification of trophoblastic disease based on its nature, in: “Human Reproduction,” K. Semm and L. Mettler, eds., Excerpta Medica, AmsterdamOxford-Princeton (1981).Google Scholar
  27. 27.
    Takeuchi, S., Nature of invasive mole and its rational management, Seminars in Oncology 9:181 (1982).PubMedGoogle Scholar
  28. 28.
    Kato, M., Tanaka, K., and Takeuchi, S., The nature of trophoblastic disease initiated by transplantation into the immunosuppressed animals, Amer. J. Obstet. Gynecol. 142:497 (1982).Google Scholar
  29. 29.
    Kajii, T., Personal communication.Google Scholar
  30. 30.
    Hertig, A. T. and Edmond, H. W., Genesis of hydatidiform mole, Arch. Pathol. 30:260 (1940).Google Scholar
  31. 31.
    Hertig, A. T., Hydatidiform mole and chorionepithelioma, in: “Progress in Gynecology,” J. V. Meigs and S. H. Sturgis, eds., Vol. 2 (1950), p. 372.Google Scholar
  32. 32.
    Takeuchi, S., Hando, T., Honda, T., Ohno, T., and Kanazawa, The nature of “trophoblastic tumours”: immunological and pathological approach, J. Asian Fed. Obstet. Gynecol. 2: 218 (1971).Google Scholar
  33. 33.
    Tokunaga, A., Studies of humoral immunological response on the aborted trophoblasts (in Japanese), J. Japan Assoc. Obstet. Gynecol. 33:2125 (1981).Google Scholar
  34. 34.
    Hanoka, J. and Takeuchi, S., Individual specificity of blocking antibodies in molar and normal term placenta-bound IgGs, Amer. J. Reprod. Immunol. in press (1983).Google Scholar
  35. 35.
    Unpublished data.Google Scholar
  36. 36.
    Lawler, S. D., HLA and trophoblastic tumors, Brit. Med. Bull. 34:30- (1978).Google Scholar
  37. 37.
    Faulk, W. P. and Temple, A., Distribution of E2 microglobulin and HLA in chorionic villi of human placentae, Nature 262: 799 (1976).PubMedCrossRefGoogle Scholar
  38. 38.
    Billingham, R. B. and Head, J. R., Current trends in reproductive immunology: an overview, J. Rep. Immunol. 3:253 (1981).CrossRefGoogle Scholar
  39. 39.
    Loke, Y. W., Joysey, V. C., and Borland, HL-A antigens on human trophoblast cell, Nature 232:403 (1971).PubMedCrossRefGoogle Scholar
  40. 40.
    Chatterjee-Hasrouni, S. and Lala, P., Localization of H-2 antigens on mouse trophoblast cell, J. Exptl. Med. 149:1238 (1979).CrossRefGoogle Scholar
  41. 41.
    Sellens, M. H., Jenkinson, E. J., and Bellington, W. D., Major histocompatibility complex and non-major histocompatibility complex antigens on mouse ectoplacental cone and placental trophoblastic cells, Transplantation 25:173 (1978).PubMedCrossRefGoogle Scholar
  42. 42.
    Wegman, T. S., The presence of class 1 MHC antigens at the maternal-fetal interface and hypotheses concerning the survival of the murine fetal allograft, J. Reprod. Immunol. 3:267 (1981).CrossRefGoogle Scholar
  43. 43.
    Sunderland, C. A., Redman, C. W. G., Stirrat, G. M., HLA A, B, C antigens are expressed on nonvillous trophoblast of the early human placenta, J. Immunol. 127:2614 (1981).PubMedGoogle Scholar
  44. 44.
    Sunderland, C. A., Naiem, M., Mason, D. Y., Redman, C. W. G., and Stirrat, G. M., The expression of major histocompatibility antigens by human chorionic villi, J. Reprod. Immunol. 3: 323 (1981).PubMedCrossRefGoogle Scholar
  45. 45.
    Chatterjee-Hasrouni, S. and Lala, P. K., In situ localization of paternal H-2 K antigens on murine trophoblast cells, Amer. J. Reprod. Immunol. 2:170 (1982).Google Scholar
  46. 46.
    Montgomery, B. and Lala, P. K., Major histocompatibility antigens on human trophoblast cells, Amer. J. Reprod. Immunol. 2:171 (1982).Google Scholar
  47. 47.
    Brami, C. J., Sanyal, M. D., Johnson, C. C., Kohorn, E. I., Dwyer, J. M., and Naftolin, F., HLA-DR antigens on cultured human trophoblast cells, Amer. J. Reprod. Immunol. 2:109 (1982).Google Scholar
  48. 48.
    Rocklin, R. E., Kitzmiller, J. L., Carpenter, C. B., Bravoy, M. R., and David, J. R., Maternal-fetal relation: absence of an immunologic blocking factor from the serum of women with chronic abortions, New Engl. J. Med. 295:1209 (1976).Google Scholar
  49. 49.
    Stimson, W. H., Strachan, A. F., and Shepherd, A., Studies on the maternal immune response to placental antigens: absence of a blocking factor from the blood of abortion-prone women, Brit. J. Obstet. Gynecol. 86:41 (1979).CrossRefGoogle Scholar
  50. 50.
    Hellstrom, K. E., Hellstrom, I., and Brawn, J., Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor, Nature 224:914 (1969).PubMedCrossRefGoogle Scholar
  51. 51.
    Hellstrom, K. E. and Hellstrom, I., The role of serum factors (“blocking antibodies”) as mediators of immunological nonreactivity to cellular antigens, in: “Ontogeny of Acquired Immunity,” Ciba Foundation Symposium, Elsevier, New York (1972), p. 133.Google Scholar
  52. 52.
    Hirschberg, H., Albrechtsen, D., Solheim, B. G., and Thorsby, E., Inhibition of human mixed leucocyte culture stimulation by anti-HLA-D-associated antisera studies with primed responding cells, Eur. J. Immunol. 7:26 (1977).PubMedCrossRefGoogle Scholar
  53. 53.
    Revillard, J. P., Robert, M., Dupont, E., et al., Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy, Transplant. Proc. 5:331 (1975).Google Scholar
  54. 54.
    Pence, H., Petty, W. H., and Rocklin, R. E., Suppression of maternal responsiveness to paternal antigen by maternal responsiveness to paternal antigen by maternal plasma, J. Immunol. 114: 525 (1975).PubMedGoogle Scholar
  55. 55.
    Riggio, R. R., Saal, S. D., Steuzel, K. H., and Rubin, A. L., Retroplacental factors and passive enhancement, Transplant. Proc. 8:281 (1976).Google Scholar
  56. 56.
    Revillard, J. P., Brocier, J., Robert M., et al., Immunologic properties of placental eluates, Transplant. Proc. 8:275 (1976).Google Scholar
  57. 57.
    Voisin, G. A. and Chaouat, G.•, Demonstration, nature, and properties of antibodies fixed on placenta and directed against paternal antigens, J. Reprod. Fertil. 21 (Suppl.): 89 (1974).Google Scholar
  58. 58.
    Moe, T., David, C. S., Rijinbeek, A. M., Nabholz, M., Miggiano, V. C., et al., Inhibition of mouse MLR by anti-Ia sera, Transplant. Proc. 7 (Suppl.):127 (1975).Google Scholar
  59. 59.
    Kajino, T., Kanazawa, K., and Takeuchi, S., Blocking effects of maternal serum-IgG and placental eluate-IgG on materno-fetal MLR and their individual specificity, Amer. J. Reprod. Immunol. in press (1983).Google Scholar
  60. 60.
    Komlos, L., Zamis, R., Johnson, H., and Halbrecht, I., Common HLA antigens in couple with repeated abortion, Clin. Immunol. Immunopath. 7:330 (1975).CrossRefGoogle Scholar
  61. 61.
    Komlos, L. and Halbrecht, I., Repeated abortions and histocompatibility antigens. Can HLA antigen restricted gene close effects influence the feto-maternal relationship? Med. Hypotheses 5:901 (1979).CrossRefGoogle Scholar
  62. 62.
    Purpma, M., Coghi, I., Micotra, M., Carapella, E., and Bottini, E., HLA Bw35 antigen and human reproduction, J. Med. Genet. 17:157 (1980).Google Scholar
  63. 63.
    Gerencer, M., Kastelan, A., Drazancic, A., Kerhin-Brkljacic, V., and Madjaric, M., The HLA antigens in women with recurrent abnormal pregnancies of unknown etiology, Tissue Antigens 12:223 (1978).PubMedCrossRefGoogle Scholar
  64. 64.
    Taylor, C. and Faulk, W. P., Prevention of recurrent abortion with leucocyte transfusions, Lancet:68 (1980).Google Scholar
  65. 65.
    Beer, A. E., Quebbeman, J. F., Ayers, J. W. T., and Haines, R. F., Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in human, Amer. J. Obstet. Gynecol. 141:987 (1981).Google Scholar
  66. 66.
    Unander, M. H. and Olding, L. B., Easily suppressed lymphocytes and absence of cytotoxic antibody in three women with habitual abortion, Amer. J. Reprod. Immunol. 2:254 (1982).Google Scholar
  67. 67.
    Aoki, K., Katahira, T., Nakane, S., et al., Search for HLA, especially DR antigen-antibody system in the couples of the unexplained habitual abortions (in Japanese), Proceeding of 33rd General Meeting of Japan Society of Obstet. Gynecol. 113 (1981).Google Scholar
  68. 68.
    Vassilakos, P., Riotton, G., and Kajii, T., Hydatidiform mole: two entities. A morphologic and cytogenetic study with some clinical considerations, Amer. J. Obstet. Gynecol. 127:167 (1977).Google Scholar
  69. 69.
    Szulman, A. E. and Surti, U., The syndrome of hydatidiform mole, I. Cytogenetic and morphologic correlation, Amer. J. Obstet. Gynecol. 131:665 (1978).Google Scholar
  70. 70.
    Szulman, A. E. and Surti, U., The syndrome of hydatidiform mole, II. Morphologic evolution of the complete and partial mole, Amer. J. Obstet. Gynecol. 132:20 (1978).Google Scholar
  71. 71.
    Lewis, J. and Hertz, R., Effects of early embryectomy and hormonal therapy on the fate of the placenta in pregnant Rhesus monkey, Proc. Soc. Exptl.’Biol. Med. 123:805 (1966).Google Scholar
  72. 72.
    Brewer, J. I. and Mazur, M. T., Gestational trophoblastic disease: morphology and pathogenesis, in: “Human Reproduction,” K. Semm and L. Mettler, eds., Excerpta Medica, AmsterdamOxford-Princeton (1981), p. 398.Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Shoshichi Takeuchi
    • 1
  1. 1.Department of Obstetrics and GynecologySchool of Medicine Niigata UniversityNiigataJapan

Personalised recommendations